Why Patient-Level Health Data Is the Next DOOH Differentiator

60+ conditions. Geographic severity indexing. 318 million patients. How epidemiological intelligence is transforming healthcare signage and pharma DOOH.

The state of the play

Healthcare signage and pharma DOOH have spent the last decade fighting the same fight: how to deliver clinically relevant content without crossing privacy lines. Most networks have settled for generic. Generic seasonal allergens. Generic flu PSAs. Generic wellness loops. The result is content that's compliant but indifferentiated — and indifferentiated content doesn't move conversion.

What patient-level data unlocks

Patient-level health intelligence — derived from licensed claims and clinical datasets covering 318 million U.S. patients — flips the model. Instead of regional allergy averages, you trigger creative on actual symptom-cluster density within a 5-mile radius. Instead of national flu PSAs, you signal-boost campaigns in counties where IQVIA reports show prescription velocity climbing. Sixty-plus conditions become addressable in near-real time.

Why this is a DOOH problem, not a healthcare problem

Pharma already buys DOOH at scale. What they haven't had is the contextual trigger layer that programmatic display has enjoyed for years. The opportunity isn't to invent new ad inventory — it's to make existing inventory smarter. A condition-indexed feed sitting behind any DSP-served panel is the missing primitive.

What we ship

Digichief licenses the data, normalizes the indices, and exposes them as triggers — a clean API that creative platforms and DSPs can consume without becoming epidemiologists. No PHI ever touches the wire. The geographic resolution is tuned for ad-targeting, not clinical use.